Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Mucus and Metabolism

Financiado

Cerrado

The relationship between the intestinal mucosal barrier and gut microbiota in me...

The relationship between the intestinal mucosal barrier and gut microbiota in metabolic diseases Obesity is a world-wide epidemic and currently about 350 million people suffer from diabetes, resulting in more than 3 million deaths per year. While the gut microbiota has been identified as a contributing factor to obesity and i... ver más

31/03/2017

UGOT - GOETEBORGS...

198K€

Presupuesto del proyecto: 198K€

Líder del proyecto

GOETEBORGS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2017-03-31 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

UGOT - GOETEBORGS UNIVERSITE...

0.00€ | Lider

Proyectos interesantes

MEDMOTILUS

Medical Technol...

Data Science

185K€ Cerrado

AGL2012-35814

Medical Technol...

Public Health

130K€ Cerrado

EarlyLife

Medical Technol...

Data Science

2M€ Cerrado

ENERGISED

Medical Technol...

Public Health

2M€ Cerrado

MUCO-IMMUN

Medical Technol...

Immunology

166K€ Cerrado

RTI2018-093873-A-I00

Medical Technol...

Public Health

145K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

GOETEBORGS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 198K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Obesity is a world-wide epidemic and currently about 350 million people suffer from diabetes, resulting in more than 3 million deaths per year. While the gut microbiota has been identified as a contributing factor to obesity and insulin resistance in mice and humans, the underlying disease-causing mechanisms are yet to be defined. The aim of this proposal is to investigate the interactions between the gut microbiota and the intestinal mucosal barrier in metabolic disease. The human intestine is colonized by a complex microbial community with up to 1000 different species. While its composition is specific for each individual, a core gut microbiota is shared between humans. However, the composition of gut microbiota is altered in individuals who are obese, diabetic or suffer from cardiovascular disease. The high density of the gut microbiota provides a continuous challenge and potential threat to the gut epithelium. As only one single, mucus-covered cell layer separates microbes from human tissue the mucosal barrier is essential in preventing microbial translocation. One epithelial defense mechanism is the secretion of antimicrobial peptides (AMPs). These endogenous peptide antibiotics have broad-spectrum antimicrobial activity and can also modulate the composition of gut microbiota. In this proposal I will focus on the intestinal barrier between host and microbiota. I will test if and how the shifted microbial composition in metabolic diseases is associated with alterations in mucosal AMP production and function. Furthermore, I will analyze mucosa-associated microbiota in metabolic disease by using mouse models and samples from human patients. Also, I will compare the peptide repertoire in the mucus of different mouse models and human diabetes patients to identify alterations in the composition that are associated with metabolic disease. The planned investigations will help to better understand the relationship between the mucosal host barrier and metabolic disease.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores